Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seitz

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Identification of selective inhibitors of cyclin dependent kinase 4D J Carini, R F Kaltenbach, J Liu, et al.
Annals of the American Thoracic Society|November 13, 2020
Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus InfluenzaNatalie L Cobb, Neha A Sathe, Kevin I Duan, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Experimental Eye Research|July 2, 2026
Subretinal injection in the USH1CR31* pig model leads to chorioretinal atrophy that limits evaluation of efficacy of an AAV-mediated gene therapyRuslan Nyshchuk, Joshua Klein, Immanuel P Seitz, et al.
The New England Journal of Medicine|October 24, 2022
Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical VentilationMatthew W Semler, Jonathan D Casey, Bradley D Lloyd, et al.
Journal of Biomedical Informatics|May 30, 2026
Multisite evaluation of automated electronic case report form data entry from electronic health recordsAlex C Cheng, Mary K Banasiewicz, Kevin W Gibbs, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)Eddy W Yue, C Anne Higley, Susan V DiMeo, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Journal of Medicinal Chemistry|November 13, 2004
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinasesJay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.
JAMA|October 14, 2023
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical TrialEdward T Qian, Jonathan D Casey, Adam Wright, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Identification of selective inhibitors of cyclin dependent kinase 4D J Carini, R F Kaltenbach, J Liu, et al.
Annals of the American Thoracic Society|November 13, 2020
Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus InfluenzaNatalie L Cobb, Neha A Sathe, Kevin I Duan, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Experimental Eye Research|July 2, 2026
Subretinal injection in the USH1CR31* pig model leads to chorioretinal atrophy that limits evaluation of efficacy of an AAV-mediated gene therapyRuslan Nyshchuk, Joshua Klein, Immanuel P Seitz, et al.
The New England Journal of Medicine|October 24, 2022
Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical VentilationMatthew W Semler, Jonathan D Casey, Bradley D Lloyd, et al.
Journal of Biomedical Informatics|May 30, 2026
Multisite evaluation of automated electronic case report form data entry from electronic health recordsAlex C Cheng, Mary K Banasiewicz, Kevin W Gibbs, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)Eddy W Yue, C Anne Higley, Susan V DiMeo, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Journal of Medicinal Chemistry|November 13, 2004
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinasesJay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.
JAMA|October 14, 2023
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical TrialEdward T Qian, Jonathan D Casey, Adam Wright, et al.
Pageof 28